JP2016501066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501066A5 JP2016501066A5 JP2015542401A JP2015542401A JP2016501066A5 JP 2016501066 A5 JP2016501066 A5 JP 2016501066A5 JP 2015542401 A JP2015542401 A JP 2015542401A JP 2015542401 A JP2015542401 A JP 2015542401A JP 2016501066 A5 JP2016501066 A5 JP 2016501066A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- composition
- blood vessel
- subject
- effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261726250P | 2012-11-14 | 2012-11-14 | |
| US61/726,250 | 2012-11-14 | ||
| PCT/IB2013/060145 WO2014076660A1 (en) | 2012-11-14 | 2013-11-14 | Vascular embolic system |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018032093A Division JP2018086425A (ja) | 2012-11-14 | 2018-02-26 | 血管塞栓システム |
| JP2019091205A Division JP2019122875A (ja) | 2012-11-14 | 2019-05-14 | 血管塞栓システム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501066A JP2016501066A (ja) | 2016-01-18 |
| JP2016501066A5 true JP2016501066A5 (enExample) | 2019-02-14 |
Family
ID=49725176
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542401A Pending JP2016501066A (ja) | 2012-11-14 | 2013-11-14 | 血管塞栓システム |
| JP2018032093A Pending JP2018086425A (ja) | 2012-11-14 | 2018-02-26 | 血管塞栓システム |
| JP2019091205A Pending JP2019122875A (ja) | 2012-11-14 | 2019-05-14 | 血管塞栓システム |
| JP2021114234A Withdrawn JP2021164739A (ja) | 2012-11-14 | 2021-07-09 | 血管塞栓システム |
| JP2023103314A Pending JP2023115128A (ja) | 2012-11-14 | 2023-06-23 | 血管塞栓システム |
| JP2024231414A Pending JP2025031996A (ja) | 2012-11-14 | 2024-12-26 | 血管塞栓システム |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018032093A Pending JP2018086425A (ja) | 2012-11-14 | 2018-02-26 | 血管塞栓システム |
| JP2019091205A Pending JP2019122875A (ja) | 2012-11-14 | 2019-05-14 | 血管塞栓システム |
| JP2021114234A Withdrawn JP2021164739A (ja) | 2012-11-14 | 2021-07-09 | 血管塞栓システム |
| JP2023103314A Pending JP2023115128A (ja) | 2012-11-14 | 2023-06-23 | 血管塞栓システム |
| JP2024231414A Pending JP2025031996A (ja) | 2012-11-14 | 2024-12-26 | 血管塞栓システム |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US20160287744A1 (enExample) |
| EP (1) | EP2919826B1 (enExample) |
| JP (6) | JP2016501066A (enExample) |
| HK (1) | HK1215200A1 (enExample) |
| WO (1) | WO2014076660A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435211A (zh) | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
| EP2869903B1 (en) | 2012-07-06 | 2018-11-28 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
| US20160287744A1 (en) * | 2012-11-14 | 2016-10-06 | 3-D Matrix Ltd. | Vascular embolic system |
| ES3037364T3 (en) | 2014-03-10 | 2025-10-01 | 3 D Matrix Ltd | Sterilization and filtration of peptide compositions |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| DK3116896T3 (en) | 2014-03-10 | 2019-03-18 | 3 D Matrix Ltd | SELF-PREPARING PEPTIME COMPOSITIONS |
| US10235906B2 (en) | 2014-11-18 | 2019-03-19 | Maximum Fidelity Surgical Simulations, LLC | Post mortem reconstitution of circulation |
| WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
| CN109195640A (zh) * | 2016-03-18 | 2019-01-11 | 立美基股份有限公司 | 脑脊液漏堵塞 |
| US20190091376A1 (en) * | 2016-03-18 | 2019-03-28 | 3-D Matrix, Ltd. | Preventing Biological Tissue Adhesion |
| US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
| PE20200719A1 (es) | 2017-11-13 | 2020-07-21 | Maximum Fidelity Surgical Simulations Llc | Reconstitucion de la circulacion posmortem, metodos y procedimientos especializados |
| US11716989B2 (en) | 2019-04-16 | 2023-08-08 | Maximum Fidelity Surgical Simulations, LLC | Cadaver preservation systems and methods |
| US11915610B2 (en) | 2019-05-15 | 2024-02-27 | Maximum Fidelity Surgical Simulations, LLC | Cadaverous heart model |
| CN115397454A (zh) | 2020-03-31 | 2022-11-25 | 立美基股份有限公司 | 通过辐照对自组装肽进行灭菌 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10127754A (ja) * | 1996-11-06 | 1998-05-19 | Koken Co Ltd | コラーゲンからなる塞栓材 |
| DK1355566T3 (da) * | 2000-12-18 | 2013-03-04 | Univ Texas | Lokal regional kemoterapi og radioterapi ved anvendelse af hydrogel in situ |
| US7449180B2 (en) | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
| US7179784B2 (en) | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
| US7713923B2 (en) | 2003-06-25 | 2010-05-11 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
| CA2572964C (en) | 2004-07-06 | 2018-03-06 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| US7790699B2 (en) * | 2004-10-12 | 2010-09-07 | Fmc Biopolymer As | Self-gelling alginate systems and uses thereof |
| GB0500643D0 (en) | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
| US9162005B2 (en) | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
| KR20100102750A (ko) | 2005-04-25 | 2010-09-24 | 메사추세츠 인스티튜트 오브 테크놀로지 | 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법 |
| US8299032B2 (en) | 2005-06-27 | 2012-10-30 | Menicon Co., Ltd. | Self-assembling peptide and gel produced from the same |
| JP5121172B2 (ja) | 2005-07-01 | 2013-01-16 | 日本合成化学工業株式会社 | 血管一時塞栓材料、その製造方法、および血管一時塞栓剤 |
| US8361454B2 (en) | 2005-07-01 | 2013-01-29 | The Nippon Synthetic Chemical Industry Co., Ltd. | PVA particle for temporary embolic material and production process thereof, and temporary embolic material |
| JP5263756B2 (ja) | 2005-09-30 | 2013-08-14 | 国立大学法人 岡山大学 | 細胞の培養方法および細胞培養物 |
| HUE037994T2 (hu) | 2006-04-25 | 2018-09-28 | Massachusetts Inst Technology | Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására |
| EP2066697A2 (en) | 2006-09-26 | 2009-06-10 | Massachusetts Institute of Technology | Modified self-assembling peptides |
| JP5558104B2 (ja) | 2006-12-11 | 2014-07-23 | スリー−ディー マトリックス， インコーポレイテッド | 心組織の保護および再生のための組成物および方法 |
| US9415084B2 (en) | 2007-03-14 | 2016-08-16 | Arch Biosurgery, Inc. | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| US9987221B2 (en) * | 2007-08-23 | 2018-06-05 | Boston Scientific Scimed, Inc. | Injectable hydrogel compositions |
| ES2534770T3 (es) | 2007-12-05 | 2015-04-28 | 3-D Matrix, Ltd. | Material para la curación de heridas y la reconstrucción de la piel |
| JP4422191B1 (ja) | 2008-09-30 | 2010-02-24 | ゼライス株式会社 | 架橋ゼラチン、塞栓剤および架橋ゼラチンの製造方法 |
| CN105435211A (zh) * | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
| US8962784B2 (en) | 2008-12-19 | 2015-02-24 | Ethicon, Inc. | Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant |
| JP2012100680A (ja) * | 2009-03-04 | 2012-05-31 | Terumo Corp | 血管内用処置材 |
| WO2010103887A1 (ja) | 2009-03-09 | 2010-09-16 | 株式会社メニコン | 自己組織化ペプチドおよび高強度ペプチドゲル |
| KR101764439B1 (ko) | 2009-04-22 | 2017-08-02 | 머케이터 메드시스템즈, 인크. | 국소 혈관 운반으로 고혈압을 치료하는 구아네티딘의 용도 |
| US20120123355A1 (en) * | 2009-07-30 | 2012-05-17 | Cook Medical Technologied | Erodible embolization material |
| US20110117195A1 (en) * | 2009-11-18 | 2011-05-19 | National Cheng Kung University | Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers |
| WO2011072482A1 (en) | 2009-12-14 | 2011-06-23 | The University Of Hong Kong | Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| EP2351779B1 (en) | 2010-01-27 | 2019-04-24 | Biosphere Medical, Inc. | Microspheres and method of making the microspheres |
| US8741833B2 (en) | 2010-07-16 | 2014-06-03 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
| WO2012133608A1 (ja) * | 2011-03-30 | 2012-10-04 | 東レ株式会社 | 生分解性粒子、血管塞栓材料及び生分解性粒子の製造方法 |
| JP6034868B2 (ja) | 2011-09-02 | 2016-11-30 | 株式会社スリー・ディー・マトリックス | 胸部の空気漏れ閉塞のための両親媒性ペプチド |
| US20150105336A1 (en) | 2012-03-09 | 2015-04-16 | 3-D Matrix, Ltd. | Mucosa-elevating agent |
| EP2869903B1 (en) | 2012-07-06 | 2018-11-28 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
| US20160287744A1 (en) * | 2012-11-14 | 2016-10-06 | 3-D Matrix Ltd. | Vascular embolic system |
| HK1220116A1 (zh) | 2013-03-06 | 2017-04-28 | 3-D Matrix Ltd. | 使用纯化的两亲性多肽组合物的外科手术方法 |
| WO2014141160A1 (en) | 2013-03-14 | 2014-09-18 | 3-D Matrix, Ltd | Treatment for bile leakage |
| CA2905182A1 (en) | 2013-03-14 | 2014-09-18 | 3-D Matrix, Ltd. | Materials for gastrointestinal obstruction prevention |
| WO2015027203A1 (en) | 2013-08-22 | 2015-02-26 | Arch Biosurgery, Inc. | Implantable meshes for controlling the movement of fluids |
| ES3037364T3 (en) | 2014-03-10 | 2025-10-01 | 3 D Matrix Ltd | Sterilization and filtration of peptide compositions |
| WO2015138475A1 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Self-assembling peptides as bronchial obstruction agents |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| JP2017513927A (ja) | 2014-03-10 | 2017-06-01 | 株式会社スリー・ディー・マトリックス | 肺の漏出を治療するための自発組織化ペプチド |
| DK3116896T3 (en) | 2014-03-10 | 2019-03-18 | 3 D Matrix Ltd | SELF-PREPARING PEPTIME COMPOSITIONS |
| JP2017519568A (ja) | 2014-06-20 | 2017-07-20 | 株式会社スリー・ディー・マトリックス | 骨間隙を充填するための材料および方法 |
| BR112016029517A2 (pt) | 2014-06-20 | 2018-06-19 | 3 D Matrix Ltd | materiais e métodos para enchimento de vácuo do osso dentário |
| WO2016075977A1 (ja) | 2014-11-14 | 2016-05-19 | 株式会社スリー・ディー・マトリックス | 自己組織化ペプチド修飾キトサンナノ会合体の合成とプロテインデリバリーへの応用 |
| EP3262155A1 (en) | 2015-02-25 | 2018-01-03 | 3-D Matrix, Ltd | Synthetic peptide hydrogel formulations for use as extracellular matrix |
-
2013
- 2013-11-14 US US14/442,677 patent/US20160287744A1/en not_active Abandoned
- 2013-11-14 HK HK16103152.0A patent/HK1215200A1/zh unknown
- 2013-11-14 JP JP2015542401A patent/JP2016501066A/ja active Pending
- 2013-11-14 WO PCT/IB2013/060145 patent/WO2014076660A1/en not_active Ceased
- 2013-11-14 EP EP13802115.9A patent/EP2919826B1/en active Active
-
2018
- 2018-02-26 JP JP2018032093A patent/JP2018086425A/ja active Pending
-
2019
- 2019-05-14 JP JP2019091205A patent/JP2019122875A/ja active Pending
-
2021
- 2021-07-09 JP JP2021114234A patent/JP2021164739A/ja not_active Withdrawn
- 2021-11-24 US US17/535,470 patent/US20220168462A1/en not_active Abandoned
-
2023
- 2023-06-23 JP JP2023103314A patent/JP2023115128A/ja active Pending
-
2024
- 2024-12-26 JP JP2024231414A patent/JP2025031996A/ja active Pending
-
2025
- 2025-06-12 US US19/235,902 patent/US12629446B2/en active Active
-
2026
- 2026-03-26 US US19/629,304 patent/US20260199545A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Deng et al. | STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib | |
| Liu et al. | Ultrasound-mediated destruction of paclitaxel and oxygen loaded lipid microbubbles for combination therapy in ovarian cancer xenografts | |
| JP2014513722A5 (enExample) | ||
| JP2016513523A5 (enExample) | ||
| JP2012107063A5 (enExample) | ||
| ES2657901T3 (es) | Utilidad ampliada de las micropartículas derivadas de glóbulos rojos (RMP) para el tratamiento de la hemorragia | |
| CN104906049B (zh) | 一种海藻酸钠微球血管栓塞剂及其制备方法 | |
| Zhang et al. | Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation | |
| CN115337281B (zh) | 一种靶向的工程化载药杂化细胞膜囊泡的制备方法及其应用 | |
| US10220019B2 (en) | Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide | |
| CN105520934A (zh) | 含笑内酯二甲基胺的应用 | |
| Soliman et al. | Miktoarm star micelles containing curcumin reduce cell viability of sensitized glioblastoma | |
| AU2025204816A1 (en) | Fibroblasts and microvesicles thereof for reduction of toxicity associated with cancer immunotherapy | |
| Li et al. | Challenges of mesenchymal stem cells in the clinical treatment of COVID-19 | |
| CN107921075B (zh) | 用于治疗肿瘤的细小病毒制剂 | |
| US20200199681A1 (en) | Mda-7 cancer therapies and methods of detecting biomolecules | |
| CN110279673B (zh) | AuNP@PP/poly(I:C)及其制备方法与其在制备治疗胶质瘤药物中的应用 | |
| TW201420130A (zh) | 溶解有二氧化碳之液狀藥劑及其投藥方法 | |
| CA3002679A1 (en) | Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease | |
| Bi et al. | Host angiogenic reprogramming by Echinococcus multilocularis protoscoleces protein via PDGFR/PI3K/AKT cascade | |
| CN105287467A (zh) | 胍丁胺在制备治疗脓毒症血管内皮损伤药物中的用途 | |
| CN120617283A (zh) | 基于dna损伤激活nkt细胞的抗白血病药物组合物及其应用 | |
| Baymishev et al. | Metrolek-O medicine use for the correction of dairy cows reproductive function | |
| He et al. | Anatomical and clinical study of lingual arterial chemoembolization for tongue carcinoma | |
| Szalata et al. | cannabidiol as a novel drug delivery strategy for treating |